View Document Preview and Link Document Date: 2013-05-26 18:40:15 Open Document File Size: 612,60 KB Share Result on Facebook
City Cambridge / Durham / / Company Millenium Pharmaceuticals Inc. / IgG / J. Pharm / Genzyme Corp. / Expert Reviews Ltd / McGraw-Hill / / Country United States / / / Facility Duke University / Duke University Medical Center / / / IndustryTerm therapy for infantile glycogen storage disease / potential clinical applications / aforementioned immunomodulatory protocol / treatment algorithms / immunomodulatory protocols / therapy for Pompe disease / technology transfer / / MedicalCondition mucopolysaccharidoses / JE / disease / neutropenia / thrombocytopenia / diabetes / infantile glycogen storage disease / hepatitis B / peripheral neuropathy / Nephrotic syndrome / Fabry disease / Inherited Disease / murine pompe disease / multiple sclerosis / diseases / progressive multifocal leuko encephalopathy / lysosomal storage diseases / lysosomal storage disease / infection / deficiency / lethal hypersensitivity / infectious agents / hemophilia / / MedicalTreatment gene therapy / enzyme replacement therapy / vaccination / plasmapheresis / / Organization Duke University / Banugaria Division of Medical Genetics / Patel Division of Medical Genetics / Gaucher Disease Registry Advisory Board for Genzyme Corporation / ERT administration / FDA / Division of Medical Genetics / Department of Pediatrics / Pompe / European Union / Duke University Medical Center / / Person Nat / Priya S Kishnani / / / Position Author / Porter / / Product Velcade / cyclophosphamide / Myozyme / azathioprine / / Technology gene therapy / alpha / aforementioned immunomodulatory protocol / antibodies / treatment algorithms / genotype / / URL www.expert-reviews.com / / SocialTag 
Editorial For reprint orders, please contact [removed] Immune modulation in Pompe disease treated with enzyme replacement therapy Expert Rev. Clin. Immunol. 8(6), 497–[removed])